Abstract Electronic supplementary material: The online version of this article (10.1007/s00406-020-01191-2) contains supplementary material, which is available to authorized users.…
Abstract There is an established, link between psychosis and metabolic abnormalities, such as altered glucose metabolism and dyslipidemia, which often…
Abstract Background: Approximately 188 million people use cannabis yearly worldwide, and it has recently been legalised in 11 US states,…
Abstract Importance: Experimental and epidemiological studies implicate the cannabinoid 1 receptor (CB1R) in the pathophysiology of psychosis. However, whether CB1R…
Abstract Rationale: While cannabis-based medicinal products have been shown to be effective for numerous neurological and psychiatric disorders, the evidence…